For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05174169
NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Gastrointestinal
Study Status:
Open to Accrual
Principal investigator:
Gang Chen, MD, PhD
IRB number :
1928835
Study Number:
NRG-GI008
Phone:
Fax:
NRG-LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Geoffrey Neuner, MD
IRB number :
2323809
Study Number:
NRG-LU008
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05624996?term=nrg-lu008&limit=10&sort=@relevance&rank=1
PrE01702: Prospective Non-Interventional Study Comparing Standard of Care Osimertinib +/- Chemotherapy for EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
2283181
Study Number:
Pre01702
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06538038?term=pre1702&limit=10&sort=@relevance&rank=1
RTOG R1216: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Head and Neck
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
483559
Study Number:
RTOG R1216
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT01810913
S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Leukemia/Lymphoma/Myeloma
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan Li, MD
IRB number :
2184196
Study Number:
S2209
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05561387